Evaluation of Pharmacokinetic and Pharmacodynamic Interaction Between Repaglinide and Atazanavir in Healthy, Diabetic and Hepatic Impaired Rats: Possible Inhibition of CYP3A, OATP, and P-Glycoprotein Transporters. ADMET DMPK 2016, 4 (3), 269-279. https://doi.org/10.5599/admet.4.3.328.